CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-09). The draft was written by AI, all 5 cited sources were opened and checked for existence, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 142 · Search date 2026-07-09 · Methodology v0.6

Elderberry,
does it really help with Colds, influenza, and immunity?

30-Second Summary
C
Evidence Grade C · 53 · Safety caution
The symptom-relief signal should be separated from prevention and immune-enhancement claims
What the
research shows
Elderberry has signals from small human RCTs and a meta-analysis suggesting that it shortened the duration of cold and influenza symptoms. However, large independent RCTs proving effects on prevention, general immune enhancement, or reduction of severe influenza complications are lacking.
What the
ads claim
Advertising combines phrases such as 'immunity,' 'cold prevention,' 'flu season,' and 'antioxidant anthocyanins.' The actual human evidence is concentrated mainly on symptom duration and symptom scores after people have already developed a cold or influenza.
*

Useful facts when choosing a product

  • Because many studies used commercial syrups or extracts, it is difficult to generalize the findings to whole-fruit teas, gummies, or low-dose products.
  • Raw berries, leaves, and stems contain components that can cause vomiting and diarrhea, so processing status matters.
  • Data are limited for people with autoimmune diseases, people taking immunosuppressants, and pregnant or breastfeeding people.
  • This is not evidence that elderberry replaces infection treatments or the effects of vaccines.
Gap Measurement · Verdict 142 · C 53
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Zakay-Rones 2004 reported in a placebo-controlled trial of 60 influenza patients that symptom relief in the elderberry syrup group was about 4 days faster. Tiralongo 2016 was an RCT of 312 long-haul air travelers and did not clearly reduce the number of cold episodes, but symptom duration and scores were lower among participants who developed colds. Hawkins 2019 meta-analysis pooled 4 RCTs and reported reduced upper respiratory symptoms, but the sample and formulations were limited. The Cochrane review of complementary therapies for influenza judged the elderberry evidence to be limited, making a firm conclusion difficult.

02

Why this is classified as C (53)

Because there are symptom-relief RCTs and a meta-analysis, this is close to the upper part of C, but prevention and immune generalization are weak and large independent RCTs are lacking. I place it at C, 53 points.

Counterpoint. If the claim is narrowed to the duration of cold and influenza symptoms, there is a positive signal. But if it is broadened to overall 'immune enhancement,' the evidence density drops sharply.

Rejudgment record. Draft — Human RCT and meta-analysis signals exist, but studies are small, independence is limited, and prevention/immunity generalization is insufficient

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Zakay-Rones Z et al. 2004Randomized double-blind placebo-controlled trial60Commercial Sambucol product study; funding source not fully independentTime to influenza symptom relief and symptom scoresReported that symptom relief in the elderberry syrup group was about 4 days faster than with placebo.Core
Tiralongo E et al. 2016Randomized double-blind placebo-controlled trial312Supported by Iprona AG; product providedCold occurrence, cold duration, and symptom scoresCold-occurrence prevention was not clear, and there were signals for reduced duration and severity among participants who developed colds.Core
Hawkins J et al. 2019Systematic review and meta-analysis4MixedUpper respiratory symptomsReported a reduction in upper respiratory symptoms in the elderberry supplementation group, but the number of studies was small.Core
Vohra S et al. 2006Cochrane reviewNon-profit reviewTreatment/prevention of influenza and influenza-like illnessSummarized that evidence for complementary therapies including elderberry was limited.Supporting
§

Receipt — 5 References

Every cited source was opened and checked against the live page on 2026-07-09.

Zakay-Rones Z, Thom E, Wollan T, Wadstein J. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. J Int Med Res. 2004;32:132-140. PMID: 15080016. DOI: 10.1177/147323000403200205.
checked
Tiralongo E, Wee SS, Lea RA. Elderberry supplementation reduces cold duration and symptoms in air-travellers: a randomized, double-blind placebo-controlled clinical trial. Nutrients. 2016;8:182. PMID: 27023596. DOI: 10.3390/nu8040182.
checked
Hawkins J, Baker C, Cherry L, Dunne E. Black elderberry supplementation effectively treats upper respiratory symptoms: a meta-analysis of randomized, controlled clinical trials. Complement Ther Med. 2019;42:361-365. PMID: 30670267. DOI: 10.1016/j.ctim.2018.12.004.
checked
Vohra S, Johnston BC, Laycock KL, et al. Complementary and alternative medicine for the treatment and prevention of influenza and influenza-like illness. Cochrane Database Syst Rev. 2006;CD005976. DOI: 10.1002/14651858.CD005976.pub2.
checked
NCCIH. Elderberry: Usefulness and Safety.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-09 · Corrections: none

Cite this verdict

Elderberry (Sambucus nigra) x colds, influenza, and immunity Evidence Grade C card
[Chamgap] Elderberry (Sambucus nigra) x colds, influenza, and immunity — Evidence Grade C·53. 5 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/immunity/elderberry-cold-flu-immune/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.